Acute graft-versus-host disease (aGVHD), mediated by CD4(+) and CD8(+) effector T cells, is a life-threatening complication in hematopoietic stem cell transplantation. CD4(+)CD25(hi) regulatory T cells (T(reg)) have been shown to modulate tolerance to aGVHD in murine models. Based on these observations, we examined their role in the prevention of aGVHD in patients who underwent transplantation with peripheral blood-mobilized hematopoietic stem cells after administration of granulocyte colony-stimulating factor. The effects of the G-CSF on the phenotype, frequency, and function of CD4(+)CD25(hi) T cells were analyzed in grafts and after transplantation to determine whether these cells were regulatory T cells. CD4(+)CD25(hi) T cells could be detected at the same frequency before and after granulocyte colony-stimulating factor administration in the donors' peripheral blood. The isolation of these cells from the grafts or from the recipients' peripheral blood after transplantation revealed that they were suppressive to the same extent as T(reg) isolated from healthy volunteers. Their number and frequency were estimated in the grafts and the results indicated that protection against aGVHD was not dependent on the T(reg) amount transferred to the recipients. Similarly there was no correlation between the number of circulating CD4(+)CD25(hi) T cells in the recipients' peripheral blood during the early period after transplantation and the outcome of aGVHD.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.humimm.2008.04.008 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Relationship between immune cell traits, circulating inflammatory cytokines, and the risk of incisional hernia after gastric surgery.
Hernia
November 2024
Department of General Surgery, Huadong Hospital, Fudan University, No. 221, West Yan'an Road, Jing'an District, Shanghai, 200040, China.
Purpose: The systemic and local inflammatory response in patients after surgical operation is closely related to the quality of the wound healing. Low-quality wound healing and defects in the suture technique lead to the occurrence of incisional hernia (IH). However, the causal relationship between human circulating inflammatory cytokines, immune cell traits, and the risk of IH remains unclear.
View Article and Find Full Text PDFArticle Synopsis
- Lanthionine synthetase C-like 2 (LANCL2) is identified as a key immunoregulatory target in treating autoimmune diseases like systemic lupus erythematosus (SLE), with the investigational drug NIM-1324 aimed at improving patient outcomes.
- In laboratory models, mice lacking LANCL2 exhibited severe symptoms of inflammation, while treatment with NIM-1324 enhanced regulatory T cell populations and reduced harmful inflammatory T cells, leading to overall better health markers.
- NIM-1324 also showed efficacy in human immune cells from SLE patients, lowering pro-inflammatory cytokines and supporting a more balanced immune response, indicating its potential as a therapeutic option.
Infection Affects the Tumor Immune Microenvironment of Esophageal Cancer Patients.
Anticancer Res
September 2024
Department of Clinical Research in Tumor Immunology, Osaka University Graduate School of Medicine, Osaka, Japan.
Background/aim: We herein examined T cell immunity in esophageal cancer patients with and without Helicobacter pylori infection to establish a foundation for immunotherapeutic strategies targeting esophageal cancer in the presence of H. pylori infection.
Materials And Methods: Twenty-six patients with esophageal squamous cell carcinoma between 2015 and 2017 were enrolled in the present study.
The Biologic IRL201805 Alters Immune Tolerance Leading to Prolonged Pharmacodynamics and Efficacy in Rheumatoid Arthritis Patients.
Int J Mol Sci
April 2024
Academic Department of Rheumatology, Centre for Inflammation Biology and Cancer Immunology (CIBCI), King's College London Faculty of Life Sciences and Medicine, Guy's Hospital Campus, London SE1 1UL, UK.
A homologue of binding immunoglobulin protein/BiP-IRL201805 alters the function of immune cells in pre-clinical in vivo and in vitro studies. The aim of the study was to select biomarkers that clearly delineate between RA patients who respond to IRL201805 and placebo patients and reveal the immunological mode of action of IRL201805 driving the extended pharmacodynamics observed in responding patients. Biomarkers that distinguished between responding patients and placebo patients included downregulation of serum interferon-γ and IL-1β; upregulation of anti-inflammatory mediators, serum soluble CTLA-4, and intracellular monocyte expression of IDO; and sustained increased CD39 expression on CD3CD4CD25 CD127 regulatory T cells.
View Article and Find Full Text PDFUnraveling the causal role of immune cells in gastrointestinal tract cancers: insights from a Mendelian randomization study.
Front Immunol
March 2024
Department of General Surgery, Anqing Municipal Hospital, Anqing, Anhui, China.
Background: Despite early attempts, the relationship between immune characteristics and gastrointestinal tract cancers remains incompletely elucidated. Hence, rigorous and further investigations in this domain hold significant clinical relevance for the development of novel potential immunotherapeutic targets.
Methods: We conducted a two-sample Mendelian randomization (MR) analysis using the tools available in the "TwoSampleMR" R package.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!